
|Articles|June 8, 2012
- The Column-06-08-2012
- Volume 8
- Issue 10
Practical Application of Quality by Design Principles to The Development of an HPLC Assay Method for an API and Impurities
A method for the assay of an active pharmaceutical ingredient (API) and five known and unknown impurities was developed in accordance with Quality by Design (QbD) principles.
Advertisement
A method for the assay of an active pharmaceutical ingredient (API) and five known and unknown impurities was developed in accordance with Quality by Design (QbD) principles. Highly influential separation parameters were simultaneously and systematically studied so that the quality of the HPLC method could be understood, controlled and ensured. Consequently, during routine analysis out of specification (OOS) results can be corrected more effectively.
Articles in this issue
over 14 years ago
Cocaine cuttingover 14 years ago
4th International Conference on Polyolefin Characterizationover 14 years ago
Baby foodover 14 years ago
Cancer profilingover 14 years ago
Market Profile: Laboratory Information Management Systemsover 14 years ago
Quality controlAdvertisement
Related to this article

This week, Chromatography Online explored how the technique is advancing wastewater drug monitoring, siRNA method development, and food safety testing, with previews of RAFA 2026 and a return to HPLC fundamentals with Michael Dong.

Recent EU legislation on PFAS shifts from monitoring individual compounds toward managing them as a chemical class.

In this seventh part of " Conversations with Michael Dong," a series on fundamentals of HPLC in pharmaceutical analysis, LCGC International’s "Perspectives in HPLC" column editor explains why 2.1-mm i.d. columns are less preferred for pharmaceutical quality control.

Ultrahigh-performance liquid chromatography–quadrupole time-of-flight mass spectrometry (UHPLC–QTOF-MS) shows how soaking and cooking break down soybean fats.

Liquid chromatography–tandem mass spectrometry (LC–MS/MS) links altered metabolism to lingering symptoms in Ebola survivors.

Nicolai Zederkopff explores chromatography’s role to help implement the maximum tolerable level (MTL) framework for food adulteration to translate analytical results into compliance decisions.

Franz Berthiller (BOKU University, Austria) discusses a multilaboratory study that used retention index markers to align mycotoxin liquid chromatography–mass spectrometry (LC–MS) data.
Advertisement
Advertisement
Trending on LCGC International
1
Conversations with Michael Dong: Why 2.1-mm i.d. Columns Are Preferred for Pharmaceutical Quality Control
2
Conversations with Michael Dong: Acetonitrile and Methanol: A Comparison of Their Chromatographic Properties
3
A New Era in LC Troubleshooting Tools
4
LC–MS/MS Tracks Drugs in Australian Wastewater
5

